Needham analyst David Saxon reiterated a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of $25.00.Invest ...
Needham analyst David Saxon raised the firm’s price target on Dentsply Sirona (XRAY) to $25 from $23 and keeps a Buy rating on the shares ahead ...
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares faced a downgrade in stock rating by Jefferies from Buy to Hold, with a significant reduction in the price target to $20.00 from the previous $30.00. The firm ...
Jefferies Financial Group downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a buy rating to a hold rating ...
CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor ...
DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.44 which represents a slight increase of $0.08 or 0.41% from the prior close of $19.36. The stock opened at $19.19 and ...
CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor ...
The Bragar Eagel & Squire law firm is investigating claims against Dentsply Sirona on behalf of long-term stockholders. Six notes: 1. The law firm is looking into whether the dent ...
Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.53 which represents a slight increase of $0.09 or 0.46% from the prior close of $19.44. The stock opened at $19.41 and ...
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. (“Dentsply” or the “Company ...
The Portnoy Law Firm advises Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) investors of a class action representing investors that bought securities between February 28, 2022, and ...